Chemical reagents
Closed Special Notice Posted
- Solicitation number
- SS-NIH-6824456
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health intends to award a firm-fixed price purchase order to Life Technologies Corporation for the provision of specific chemical reagents. The reagents are required for ongoing cell culture work being conducted under a Food and Drug Administration clinical trial that can only utilize products from this vendor.
The Special Notice communicates the NIH's intent to sole source procurement of chemical reagents from Life Technologies Corporation. The reagents are needed to continue cell culture work locked into an FDA trial that precludes changes to products being used. Interested parties have until December 5th, 2023 to submit a written capability statement demonstrating their ability to fulfill requirements, though award is expected to Life Technologies in 5 days absent an alternative capable source. Only Life Technologies is currently eligible as the clinical trial requires continued use of products from this vendor. The notice lists the specific reagents and quantities required totaling over $50,000 in value.
Notice text
Notice of Intent to Sole Source
The National Institutes of Health (NIH) intends to award a Firm-Fixed Price purchase order to Life Technologies, Corp.
In accordance with FAR Part 6.302-1, the Contractor is the only known responsible source who can provide the services for the requirement listed below.
The purpose of this notice is to inform the public that the NIH anticipates issuing a purchase order to Life Technologies, Corp. for chemical reagents to continue cell culture work. The chemical reagents can only be obtained from this vendor as they are currently being used and are locked into a Food and Drug Administration’s trial and cannot be changed. Reagents to be obtained are listed below:
SKU #/PPL DESCRIPTION
1251071 MEM alpha, nucleosides, 10 x 500 ml, quantity of 50
A1517001 Essential 8 Medium, 500 ml,quantity of 50
12563029 TrypLE Select Enzyme, 500 ml, quantity of 20
12618012 CTS KnockOut SR, XenoFree Medium, 100 ml, quantity of 20
14190250 DPBS, no calcium, no magnesium, 10 x 500 ml, quantity of 10
This notice is not a request for competitive quotes. However, any party that believes it can fulfill the requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to satisfy the requirement. A determination by the Government to compete this proposed award based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued approximately five (5) days after
the date of this notice unless the Government determines that another organization has the capability to meet this requirement.
Responses to this notice must have the notice ID #SS-NIH-6824456 in the subject line of the email. Please email responses to zetherine.gore@nih.gov no later than 12:00 p.m. EST on Tuesday, December 5, 2023.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity